At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
Amantadinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
In Brief
A Phase 3 clinical trial evaluating Amantadine for Chronic Hepatitis C. Completed, across 1 site.
Detailed Summary
\* Adding Amantadine to standard anti-viral treatment can improve sustained response rates in patients with chronic hepatitis C
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Hepatitis C
CountriesNetherlands
Collaborators--
Timeline
Phase 3CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2000
First PostedSep 2005
Study CompletionJan 2007
TodayJul 2026
First PostedSep 5, 2005
Enrollment StartFeb 1, 2000
Study CompletionJan 1, 2007
TodayJul 2, 2026
Posted 20.8 years ago
Interventions
Amantadinedrug